Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OLMA Olema Pharmaceuticals, Inc.

休市中 09-04 16:00:00 EDT

10.75

+0.02

+0.19%

盘后10.86

+0.11+1.02%

19:30 EDT

最高10.85	最低10.57	成交量50.53万
今开10.61	昨收10.73	日振幅2.61%
总市值9.37亿	流通市值7.73亿	总股本8,716万
成交额542.87万	换手率0.70%	流通股本7,189万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OLMA","market":"US","secType":"STK","nameCN":"Olema Pharmaceuticals, Inc.","latestPrice":10.75,"timestamp":1788552000000,"preClose":10.73,"halted":0,"volume":505266,"hourTrading":{"tag":"盘后","latestPrice":10.86,"preClose":10.75,"latestTime":"19:30 EDT","volume":30145,"amount":324168.57,"timestamp":1788564603231,"change":0.11,"changeRate":0.010233,"amplitude":0.010233},"delay":0,"changeRate":0.0018639328984156173,"floatShares":71888100,"shares":87156961,"eps":-2.128893,"marketStatus":"休市中","change":0.02,"latestTime":"09-04 16:00:00 EDT","open":10.61,"high":10.85,"low":10.57,"amount":5428664.304486,"amplitude":0.026095,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.128893,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1605762000000,"exchange":"NASDAQ","adjPreClose":10.73,"preHourTrading":{"tag":"盘前","latestPrice":10.57,"preClose":10.73,"latestTime":"09:29 EDT","volume":719,"amount":7609.261842000001,"timestamp":1788528599999,"change":-0.16,"changeRate":-0.014911,"amplitude":0.007325},"postHourTrading":{"tag":"盘后","latestPrice":10.86,"preClose":10.75,"latestTime":"19:30 EDT","volume":30145,"amount":324168.57,"timestamp":1788564603231,"change":0.11,"changeRate":0.010233,"amplitude":0.010233},"volumeRatio":0.618632,"impliedVol":0.8648,"impliedVolPercentile":0.373},"requestUrl":"/m/hq/s/OLMA/tweets","defaultTab":"tweets","newsList":[{"id":"1157351621","title":"Olema Oncology 任命 Jason O'Byrne 为新任首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1157351621","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157351621?lang=zh_cn&edition=full","pubTime":"2026-08-13 19:05","pubTimestamp":1786619138,"startTime":"0","endTime":"0","summary":"旧金山，2026年8月13日——专注于乳腺癌等疾病靶向疗法发现、开发与商业化的临床阶段生物制药公司 Olema Pharmaceuticals, Inc.今日宣布，任命 Jason O'Byrne为首席财务官。加入 Olema 前，他在 Vir Biotechnology 担任执行副总裁兼首席财务官，领导财务、投资者关系及信息技术部门。在此之前，O'Byrne 先生曾任 Caribou Biosciences 首席财务官。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141229334","title":"Olema Pharmaceuticals完成三期Opera-01试验患者入组；顶线数据预计2027年第一季度公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1141229334","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141229334?lang=zh_cn&edition=full","pubTime":"2026-08-11 04:47","pubTimestamp":1786394843,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals公司已圆满完成三期Opera-01临床试验的患者招募工作。根据公司披露，该项试验的顶线数据预计将于2027年第一季度对外公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","OLMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117473835","title":"Olema Oncology 宣布与拜耳达成临床试验合作与供应协议，评估 Op-3136 联合 Nubeqa®（达洛鲁胺）治疗转移性去势抵抗性前列腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1117473835","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117473835?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:01","pubTimestamp":1779793303,"startTime":"0","endTime":"0","summary":"Olema Oncology 已宣布与拜耳公司达成一项临床试验合作与供应协议。双方将共同评估其候选药物 Op-3136 与拜耳的 Nubeqa®（达洛鲁胺）联合疗法，用于治疗转移性去势抵抗性前列腺癌（mCRPC）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145281350","title":"Olema Pharmaceuticals, Inc. - 针对OP-1250和达罗鲁胺的36名患者研究，预计2026年下半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1145281350","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145281350?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:01","pubTimestamp":1779793300,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals, Inc.宣布，一项旨在评估OP-1250联合达罗鲁胺治疗效果的研究即将展开。该研究计划招募36名患者参与，预计将于2026年下半年正式启动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","OLMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107407732","title":"Olema Oncology在2026年ASCO年会上公布Kat6抑制剂OP-3136一期研究的积极初步临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1107407732","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107407732?lang=zh_cn&edition=full","pubTime":"2026-05-22 05:01","pubTimestamp":1779397300,"startTime":"0","endTime":"0","summary":"在近期举行的2026年美国临床肿瘤学会（ASCO）年会上，Olema Oncology公布了其研发的Kat6抑制剂OP-3136在一期临床试验中取得的初步临床数据，结果令人鼓舞。\n该研究旨在评估OP-3136的安全性、耐受性及初步疗效。数据显示，在特定患者群体中，该候选药物展现出良好的耐受性特征，并显示了初步的抗肿瘤活性信号。这些早期发现为OP-3136的后续开发提供了支持。\n作为一家专注于开发女性癌症治疗药物的生物制药公司，Olema Pharmaceuticals, Inc.的此项进展备受关注。Kat6被认为是癌症治疗中的一个有潜力的靶点，此次积极数据进一步验证了其研发策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143357247","title":"Olema Oncology任命Prakash Raman博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1143357247","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143357247?lang=zh_cn&edition=full","pubTime":"2026-04-30 04:06","pubTimestamp":1777493180,"startTime":"0","endTime":"0","summary":"旧金山，2026年4月29日——临床阶段生物制药公司Olema Pharmaceuticals, Inc.今日宣布，任命Prakash Raman博士为其董事会成员。Olema Oncology总裁兼首席执行官Sean P. Bohen医学博士、哲学博士表示：\"在公司推进主导项目palazestrant进行两项三期临床试验及早期联合研究，并推进我们的潜在同类最佳KAT6抑制剂OP-3136的关键时刻，我们非常高兴欢迎Prakash加入Olema董事会。Raman博士自2024年4月起担任Black Diamond Therapeutics的董事会成员。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","OLMA","OP.USD.HKCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107853207","title":"Olema Pharmaceuticals Inc 持续推进Op-3136一期临床研究患者招募工作，初步数据预计2026年第二季度公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1107853207","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107853207?lang=zh_cn&edition=full","pubTime":"2026-03-16 19:11","pubTimestamp":1773659473,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals Inc (OLMA) 宣布，其研发的候选药物OP-3136的一期临床研究患者招募工作正在进行中。该公司预计，这项研究的初步数据将在2026年第二季度获得。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517625121","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大涨5.16%报4.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517625121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517625121?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:02","pubTimestamp":1741276968,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时02分，Olema Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.16%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2853.93%、1803.76%、116.69%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为68.33%、67.37%、57.40%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000248963c5e67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000248963c5e67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514334225","title":"Olema Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514334225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514334225?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:03","pubTimestamp":1740686628,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时03分，Olema Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.00%。截至发稿，该股报4.37美元/股，成交量39.0696万股，换手率0.53%，振幅6.52%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1918.01%、336.81%、188.55%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228040348abdfb74b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228040348abdfb74b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","OLMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512616517","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大涨7.44%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512616517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512616517?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889336,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，Olema Pharmaceuticals, Inc.股票出现异动，股价急速上涨7.44%。截至发稿，该股报5.34美元/股，成交量1.9712万股，换手率0.03%，振幅3.14%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为284.61%、100.54%、75.53%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Glycomimetics, Inc.，振幅分别为34.04%、22.30%、18.69%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235369627980a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235369627980a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380563","title":"Olema Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380563?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:38","pubTimestamp":1739284725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时38分，Olema Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.04%。截至发稿，该股报4.90美元/股，成交量1.4923万股，换手率0.02%，振幅4.07%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2204.98%、564.93%、215.82%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为31.80%、29.73%、25.49%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223846a241fce1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223846a241fce1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509280704","title":"Olema Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509280704?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:11","pubTimestamp":1738768269,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时11分，Olema Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.19%。截至发稿，该股报6.49美元/股，成交量3.7629万股，换手率0.05%，振幅4.98%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。其相关个股中，Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3832.05%、1123.52%、668.78%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为59.80%、58.93%、54.05%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231109961910a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231109961910a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507670894","title":"Olema Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.15%报6.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507670894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507670894?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:08","pubTimestamp":1738267725,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时08分，Olema Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.15%。截至发稿，该股报6.53美元/股，成交量121.149万股，换手率1.63%，振幅6.85%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Dominari Holdings Inc.涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1811.28%、328.81%、253.89%，振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为70.55%、65.98%、64.10%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310408459876d60b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310408459876d60b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506288305","title":"Olema Pharmaceuticals, Inc.盘中异动 大幅拉升5.04%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506288305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506288305?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:57","pubTimestamp":1737989860,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时57分，Olema Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.04%。截至发稿，该股报6.25美元/股，成交量3.5942万股，换手率0.05%，振幅6.08%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1363.88%、161.72%、82.66%，振幅较大的相关个股有阿诺医药、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为98.54%、85.35%、65.16%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722574096123da5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722574096123da5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","OLMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504194905","title":"Olema Pharmaceuticals, Inc.盘中异动 快速拉升5.11%报5.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504194905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504194905?lang=zh_cn&edition=full","pubTime":"2025-01-18 01:28","pubTimestamp":1737134939,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日01时28分，Olema Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.11%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Aditxt, Inc.、Silexion Therapeutics Corp、Phio Pharmaceuticals Corp.较为活跃，换手率分别为208.43%、37.51%、37.43%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Immatics N V C/Wts 01/07/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为53.37%、51.37%、48.07%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118012859abaed88a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118012859abaed88a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503640992","title":"Olema Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.25%报5.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503640992?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:34","pubTimestamp":1736951683,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时34分，Olema Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.25%。截至发稿，该股报5.41美元/股，成交量7.6992万股，换手率0.10%，振幅4.86%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Exicure, Inc.、Monte Rosa Therapeutics, Inc.、Lexaria Bioscience Corp.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为187.05%、59.69%、35.76%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152234439604b4e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152234439604b4e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503058582","title":"Olema Pharmaceuticals, Inc.盘中异动 大幅下跌5.16%报4.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503058582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503058582?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:35","pubTimestamp":1736778934,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时35分，Olema Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.16%。截至发稿，该股报4.78美元/股，成交量4.246万股，换手率0.06%，振幅5.75%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3316.65%、2083.23%、392.57%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、60.36%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132235349864d686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132235349864d686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501774821","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501774821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501774821?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:14","pubTimestamp":1736349280,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时14分，Olema Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.15%。截至发稿，该股报5.51美元/股，成交量73.2504万股，换手率0.99%，振幅6.49%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2585.36%、561.40%、528.20%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为154.55%、139.44%、68.53%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010823144195fd07c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010823144195fd07c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2501878307","title":"Olema Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501878307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501878307?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:08","pubTimestamp":1736262537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时08分，Olema Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.09%。截至发稿，该股报5.22美元/股，成交量31.9704万股，换手率0.43%，振幅5.73%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Hoth Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Hoth Therapeutics, Inc.、Immuneering Corporation、Scisparc Ltd.较为活跃，换手率分别为1764.75%、201.20%、119.45%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Immuneering Corporation，振幅分别为97.61%、65.47%、47.03%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010723085895fba546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010723085895fba546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501062250","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大跌5.09%报5.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501062250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501062250?lang=zh_cn&edition=full","pubTime":"2025-01-07 01:29","pubTimestamp":1736184554,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日01时29分，Olema Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.09%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Scisparc Ltd.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Alpha Tau Medical Ltd C/Wts 涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为1570.31%、363.90%、152.17%，振幅较大的相关个股有Scisparc Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为176.15%、106.67%、92.16%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010701291495fa932f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010701291495fa932f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.olema.com","stockEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":-0.0876},{"period":"3month","weight":0.0407},{"period":"6month","weight":-0.5021},{"period":"1year","weight":0.7059},{"period":"ytd","weight":-0.5708}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Olema Pharmaceuticals, Inc.于2006年8月7日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于为乳腺癌开发下一代靶向疗法。其主要候选药物palazestrant是一种口服小分子，具有雌激素受体拮抗剂和降解剂的双重活性，目前正在针对ER+/HER2-转移性乳腺癌进行3期试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.09126},{"month":2,"riseRate":0,"avgChangeRate":-0.145976},{"month":3,"riseRate":0,"avgChangeRate":-0.170468},{"month":4,"riseRate":0.333333,"avgChangeRate":0.010266},{"month":5,"riseRate":0.5,"avgChangeRate":0.014684},{"month":6,"riseRate":0.666667,"avgChangeRate":0.173907},{"month":7,"riseRate":0.5,"avgChangeRate":0.107646},{"month":8,"riseRate":0.5,"avgChangeRate":-0.010348},{"month":9,"riseRate":0.666667,"avgChangeRate":0.111712},{"month":10,"riseRate":0.4,"avgChangeRate":0.060003},{"month":11,"riseRate":0.4,"avgChangeRate":0.234387},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.111549}],"exchange":"NASDAQ","name":"Olema Pharmaceuticals, Inc.","nameEN":"Olema Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Olema Pharmaceuticals, Inc.(OLMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Olema Pharmaceuticals, Inc.,OLMA,Olema Pharmaceuticals, Inc.股票,Olema Pharmaceuticals, Inc.股票老虎,Olema Pharmaceuticals, Inc.股票老虎国际,Olema Pharmaceuticals, Inc.行情,Olema Pharmaceuticals, Inc.股票行情,Olema Pharmaceuticals, Inc.股价,Olema Pharmaceuticals, Inc.股市,Olema Pharmaceuticals, Inc.股票价格,Olema Pharmaceuticals, Inc.股票交易,Olema Pharmaceuticals, Inc.股票购买,Olema Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Olema Pharmaceuticals, Inc.(OLMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}